Ganirelix is a synthetic decapeptide compound whose acetate, Ganirelix Acetate, is a gonadotropin-releasing hormone (GnRH) receptor antagonist. The amino acid sequence is Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-Tyr-D-HomoArg(9,10-Et2)-Leu-L-HomoArg(9,10-Et2)-Pro-D-Ala-NH2.It is used clinically, primarily, in women undergoing assisted reproduction techniques in controlled ovarian stimulation programs to prevent the premature luteinizing hormone peak. premature luteinizing hormone peaks and for the treatment of fertility disorders due to this cause. The drug is characterized by fewer adverse effects, higher pregnancy rates, and shorter treatment cycles, and has significant clinical advantages over similar drugs.

Brand: Soarwin

CAS No.: 123246-29-7

Molecular Formula: C80H113ClN18O13